Date:8/9/2012

ment disputes in connection with our recent acquisitions and related impacts; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our client base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the possibility that client agreements will be terminated or not renewed; any potential impairment of goodwill or intangible assets; consolidation in the pharmaceutical industry; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing, including initiatives by our clients to perform services we offer internally; the impact of customer project delays and cancellations; our ability to convert backlog into revenue; the potential liability associated with bringing new drugs to market, including potential liability from injury to clinical trial participants; the actual impact of the adoption of certain accounting standards; and our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance. Holders of our debt instruments are referred to reports provided to investors from time to time and the offering memorandums provided in connection with the issuance of our senior secured notes for further discussion of these risks and other factors.

Media Contact James Forte Director, Public & Media Relations (919) 844-7100, x7195 jforte@campbellalliance.com

 

'/>"/>

SOURCE Pharmaceutical Institute Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
2. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
3. Texas Medicaid Managed-Care Problems Gaining National Attention
4. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
7. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
8. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
9. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
10. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
11. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare